Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akari Therapeutics PLC (NASDAQ:AKTX)

12.28
Delayed Data
As of Feb 10
 -0.165 / -1.33%
Today’s Change
4.00
Today|||52-Week Range
62.00
-15.31%
Year-to-Date
No recent news for Akari Therapeutics PLC.

Today’s Trading

Previous close12.45
Today’s open11.00
Day’s range11.00 - 12.28
Volume10,243
Average volume (3 months)7,579
Market cap$144.6M
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)-5.76%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
OVASOvaScience Inc-0.42-7.37%
AXSMAxsome Therapeutics ...+0.64+10.16%
BCRXBioCryst Pharmaceuti...-0.09-4.76%
KMDAKamada Ltd-0.03-0.82%
Data as of 02/10/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$9.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Gur A. Roshwalb
Chief Operating Officer &
Director
Clive Richardson
Corporate headquarters
London, Greater London

Forecasts

Partner Offers